Literature DB >> 23831178

Neuropsychological performance within-person variability is associated with reduced treatment consent capacity.

Ronald J Gurrera1, Michele J Karel2, Armin R Azar2, Jennifer Moye2.   

Abstract

OBJECTIVE: The capacity of older adults to make healthcare decisions is often impaired in dementia and has been linked to performance on specific neuropsychological tasks. Within-person across-test neuropsychological performance variability has been shown to predict future dementia. This study examined the relationship of within-person across-test neuropsychological performance variability to a current construct of treatment decision (consent) capacity.
METHODS: Participants completed a neuropsychological test battery and a standardized capacity assessment. Standard scores were used to compute mean neuropsychological performance and within-person across-test variability. Assessments were performed in the participant's preferred location (e.g., outpatient clinic office, senior center, or home). Participants were recruited from the community with fliers and advertisements and consisted of men (N = 79) and women (N = 80) with (N = 83) or without (N = 76) significant cognitive impairment. Participants completed the MacArthur Competence Assessment Tool-Treatment and 11 neuropsychological tests commonly used in the cognitive assessment of older individuals.
RESULTS: Neuropsychological performance and within-person variability were independently associated with continuous and dichotomous measures of capacity, and within-person neuropsychological variability was significantly associated with within-person decisional ability variability. Prevalence of incapacity was greater than expected in participants with and without significant cognitive impairment when decisional abilities were considered separately.
CONCLUSION: These findings are consistent with an emerging construct of consent capacity in which discrete decisional abilities are differentially associated with cognitive processes and indicate that the sensitivity and accuracy of consent capacity assessments can be improved by evaluating decisional abilities separately. Published by Elsevier Inc.

Entities:  

Keywords:  Decisional capacity; cognitive impairment; executive function

Mesh:

Year:  2013        PMID: 23831178      PMCID: PMC3795850          DOI: 10.1016/j.jagp.2013.03.010

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  25 in total

1.  Competence to consent to treatment as a psychological construct.

Authors:  Allan M Tepper; Amiram Elwork
Journal:  Law Hum Behav       Date:  1984-12

2.  Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard.

Authors:  D C Marson; H A Cody; K K Ingram; L E Harrell
Journal:  Arch Neurol       Date:  1995-10

3.  Tests of competency to consent to treatment.

Authors:  L H Roth; A Meisel; C W Lidz
Journal:  Am J Psychiatry       Date:  1977-03       Impact factor: 18.112

4.  Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.

Authors:  M P Dymek; P Atchison; L Harrell; D C Marson
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

Review 5.  Criteria for patient decision making (in)competence: a review of and commentary on some empirical approaches.

Authors:  S P Welie
Journal:  Med Health Care Philos       Date:  2001

6.  Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging.

Authors:  F W Unverzagt; S Gao; O Baiyewu; A O Ogunniyi; O Gureje; A Perkins; C L Emsley; J Dickens; R Evans; B Musick; K S Hall; S L Hui; H C Hendrie
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

7.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

8.  Within-person across-neuropsychological test variability and incident dementia.

Authors:  Roee Holtzer; Joe Verghese; Cuiling Wang; Charles B Hall; Richard B Lipton
Journal:  JAMA       Date:  2008-08-20       Impact factor: 56.272

9.  Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards.

Authors:  D C Marson; A Chatterjee; K K Ingram; L E Harrell
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs.

Authors:  J Brandt; K A Welsh; J C Breitner; M F Folstein; M Helms; J C Christian
Journal:  Arch Neurol       Date:  1993-06
View more
  4 in total

Review 1.  Assessment of Healthcare Decision-making Capacity.

Authors:  Barton W Palmer; Alexandrea L Harmell
Journal:  Arch Clin Neuropsychol       Date:  2016-08-22       Impact factor: 2.813

Review 2.  Determining medical decision-making capacity in brain tumor patients: why and how?

Authors:  Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven
Journal:  Neurooncol Pract       Date:  2020-07-16

3.  Hubness of strategic planning and sociality influences depressive mood and anxiety in College Population.

Authors:  Je-Yeon Yun; Yoobin Choi; Yoonhee Kwon; Hwa Young Lee; Soo-Hee Choi; Joon Hwan Jang
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

4.  Imaging the aging brain: study design and baseline findings of the SENIOR cohort.

Authors:  Alexa Haeger; Jean-François Mangin; Alexandre Vignaud; Cyril Poupon; Antoine Grigis; Fawzi Boumezbeur; Vincent Frouin; Jean-Robert Deverre; Marie Sarazin; Lucie Hertz-Pannier; Michel Bottlaender
Journal:  Alzheimers Res Ther       Date:  2020-06-26       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.